Rediffusion has announced that Rediffusion Healthcare would henceforth be known as Wellth. This re-branding becomes effective Thursday.
Wellth will report into Kalyani Srivastava, Joint President of Rediffusion.
Rediffusion Healthcare’s original avatar, Sudler & Hennessey, was launched 20 years ago, in 2022 when Rediffusion was a part of the Young & Rubicam network.
“The new branding signals that fact that Wellth is really the true Wealth for all humans. Rediffusion Healthcare has had a very illustrious past with award winning work for GSK, Dr. Reddy’s, Glenmark, Abbott, Bayer, Pfizer, Sun Pharma, Wockhardt, Cipla, Merck, Sanofi… practically all the big names of the pharma and healthcare business. The new entity brings newer competencies, new knowledge and new perspectives to this specialised domain,” said Sandeep Goyal, Managing Director of Group Rediffusion.
“We have extensive experience in running a cloud-based customisable proprietary system that is an all-encompassing HCP and patient engagement platform for multiple pharma companies in the US from India. We plan to further expand this this practice,” added Rajendra Gupta, Chief Growth Officer of Rediffusion.
It also said that in 2023, Wellth will expand its footprint to Delhi, Ahmedabad and Bangalore, in addition to its homebase, Mumbai.